机读格式显示(MARC)
- 000 02212cam a2200373 i 4500
- 008 221108s2023 flua b 001 0 eng
- 020 __ |a 9781032430836 |q hardback
- 020 __ |a 1032430834 |q hardback
- 020 __ |a 9781032431734 |q paperback
- 020 __ |a 1032431733 |q paperback
- 020 __ |z 9781003366003 |q ebook
- 035 __ |a (OCoLC)1354944104
- 040 __ |a DLC |b eng |e rda |c DLC |d OCLCF |d OCLCO
- 050 00 |a RS199.S73 |b L429 2023
- 082 00 |a 614.4/8 |2 23/eng/20221214
- 100 1_ |a LeBlanc, Destin A., |e author.
- 245 10 |a Cleaning validation : |b practical compliance approaches for pharmaceutical manufacturing / |c Destin A. LeBlanc, Consulatant, Cleaning Validation Technologies.
- 260 __ |a Boca Raton, FL : |b CRC Press, |c 2023.
- 300 __ |a xi, 203 pages : |b illustrations ; |c 24 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 504 __ |a Includes bibliographical references and index.
- 520 __ |a "Pharmaceutical manufacturers and upper management are encouraged to meet the challenges of the science-based and risk-based approaches to cleaning validation. Using some of the principles and practices in this volume will help in designing a more effective and efficient cleaning validation program. Timely coverage of cleaning validation for the pharmaceutical industry is a dynamic area in terms of health-based limits. Author encourages pharmaceutical manufacturers, and particularly upper management, to meet the challenges of the science-based and risk-based approaches to cleaning validation. Draws on the author's vast experience in the field of cleaning validation and hazardous materials. Discusses EMA vs. ISPE on Cleaning Limits and revised Risk-MaPP for highly hazardous products in shared facilities. Diverse list of topics from protocol limits for yeasts and molds to cleaning validation for homeopathic drug products"-- |c Provided by publisher.
- 650 _0 |a Pharmaceutical technology |x Quality control.